---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-081160"
form_type: "8-K"
ticker: "NVAX"
cik: "0001000694"
company_name: "NOVAVAX INC"
filed_at: "2025-08-21T23:59:59+00:00"
generated_at: "2026-05-17T10:43:46.861471+00:00"
event_type: "debt"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Novavax issues $225M in 4.625% convertible notes due 2031, refinancing 2027 notes

## Summary
- Issued $225M of 4.625% Convertible Senior Notes due 2031; exchanged ~$148.7M of 2027 notes and raised ~$49.7M new cash.
- Conversion price $11.14 per share, a 27.5% premium over the Aug 20 closing price of $8.74.
- Approximately $26.5M of 2027 notes remain outstanding; net proceeds from subscription for general corporate purposes.
- Closing expected on or about Aug 27, 2025; financial advisor JWCA plans to buy ~1.2M shares concurrently.

## SEC filing metadata
- accession: 0001104659-25-081160
- form_type: 8-K
- ticker: NVAX
- cik: 0001000694
- company_name: NOVAVAX INC
- filed_at: 2025-08-21T23:59:59+00:00
- event_type: debt
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1000694/000110465925081160/0001104659-25-081160-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1000694/000110465925081160/tm2524045d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-081160
- JSON: https://secwatch.observer/filing/0001104659-25-081160.json
- Plain text: https://secwatch.observer/filing/0001104659-25-081160.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.